

(Sharecast News) - AIM-listed biotechnology company SalvaRx has entered into a conditional sale agreement that would see the Cambridgeshire-based firm...


LONDON (Alliance News) - Shares in SalvaRx Group PLC soared on Tuesday after the company said it entered into a sale agreement for the disposal of its...


LONDON (Alliance News) - SalvaRx Group PLC said on Monday its subsidiary iOx Therapeutics Ltd has seen a significant delay in manufacturing its lead d...


LONDON (Alliance News) - Biotechnology firm SalvaRx Group PLC said Thursday it is making progress across all aspects of its business as it looks to ga...


(ShareCast News) - Cancer-focused biotechnology firm SalvaRx expanded its investment portfolio on Friday, taking a chunk of US-based Intensity Therape...


(ShareCast News) - SalvaRx announced a potential win for both shareholders and cancer patients on Thursday, with its subsidiary iOx being part of an 1...